Buy this article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this article you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.



August 2004, Volume 34 Number 8 , p 30 - 30




  • Source

    Aspirin may reduce the risk of developing breast cancer, according to new study results. Previous studies had produced conflicting evidence about the link between breast cancer and aspirin. The latest study is the first to examine aspirin's effect on the growth of certain types of breast cancer tumors.

    Researchers conducted a population-based case-control study of 1,442 women with breast cancer and 1,420 women free from disease. Compared with women who didn't use any aspirin, women who took aspirin at least four times a week for at least 3 months were almost 30% less likely to develop breast cancer involving tumors fueled by estrogen and progesterone. Aspirin didn't appear to have any effect on the risk of developing hormone receptor-negative cancer tumors.

    Aspirin's protective benefits were strongest in women who took seven or more tablets per week and in postmenopausal women. Researchers believe aspirin helps ...

To continue reading, buy this article for just $3.95.

Have a coupon or promotional code? Enter it here: